Evidence map›Paper›PMID 25856540›Full record

ArticleAnnals of medicine2015

Associations between sleep disturbances and diabetes mellitus among blacks with metabolic syndrome: Results from the Metabolic Syndrome Outcome Study (MetSO).

Alberto R Ramos, Douglas M Wallace, Seithikurippu Ratnas Pandi-Perumal, Natasha J Williams, Chimene Castor, Mary Ann Sevick, Samy I Mcfarlane, Girardin Jean-Louis

Abstract read
In one paragraph

Article in Annals of medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Increased Metabolic Burden Among Blacks: A Putative Mechanism for  Disparate COVID-19 Outcomes.Diabetes, metabolic syndrome and obesity : targets and therapy · 2020
    Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Alberto R RamosDepartment of Neurology, Miller School of Medicine, University of Miami , Miami , FL, USA.
Douglas M Wallace
Seithikurippu Ratnas Pandi-Perumal
Natasha J Williams
Chimene Castor
Mary Ann Sevick
Samy I Mcfarlane
Girardin Jean-Louis
NYU Langone Health · USUniversity of Miami · USHoward University · USSUNY Downstate Health Sciences University · US

Funding

Miami Clinical and Translational Science InstituteKL2TR000461 · NCATS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI SACCO, RALPH L. · 2012 to 2016
$2.1M
Promoting Adherence to Sleep Apnea Treatment among Blacks with Metabolic SyndromeR01MD004113 · NIMHD · SUNY DOWNSTATE MEDICAL CENTER · PI JEAN-LOUIS, GIRARDIN · 2009 to 2012
$1.7M
Tailored Sleep Health Education: A Community-Engaged ApproachR25HL116378 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ALLEGRANTE, JOHN P., JEAN-LOUIS, GIRARDIN · 2013 to 2016
$1.0M
NCATS NIH HHS 1KL2TR000461NCATS NIH HHS KL2 TR000461NHLBI NIH HHS R25 HL116378NIMHD NIH HHS R01 MD004113NIMHD NIH HHS R01MD004113
6 · The paper itself

Abstract

introductionThe association between sleep disturbances and cardiometabolic diseases has been understudied in blacks with metabolic syndrome.

methodsThis study is a cross-sectional analysis of the Metabolic Syndrome Outcome Study (MetSO) trial. We assessed insomnia symptoms, sleep duration, and risk for sleep apnea. Multivariate logistic regression models evaluated the association between sleep disturbances with diabetes mellitus (DM) and the combined outcomes of DM and hypertension as well as DM and dyslipidemia.

resultsThe sample consisted of 1,013 participants, mean age of 62 ± 14 years and 61% female. DM was diagnosed in 60% of the sample. Sleep apnea risk was observed in 48% of the sample, while 10% had insomnia symptoms and 65% reported short sleep duration (< 6 hours). Sleep apnea risk, but not insomnia or sleep duration, was associated with DM (OR 1.66; 95% CI 1.21-2.28), adjusting for age, sex, income, obesity (BMI ≥ 30 kg/m(2)), tobacco use, alcohol use, hypertension, dyslipidemia, and depression. In fully adjusted models, sleep apnea risk was associated with the combined outcome of DM-hypertension (OR 1.95; 95% CI 1.42-2.69), but not with diabetes-dyslipidemia.

conclusionWe observed a strong association between sleep apnea risk and diabetes mellitus among blacks with metabolic syndrome.

Indexed as

AgedBlack or African AmericanCross-Sectional StudiesDepressionDiabetes ComplicationsDiabetes MellitusFemaleHumansLogistic ModelsMaleMetabolic SyndromeMiddle AgedObesityOutcome Assessment, Health CareRisk FactorsSleep Wake DisordersBlack race/ethnicitydiabetes mellitusmetabolic syndromesleep apnea

Identifiers

PMID25856540
PMCPMC4659349
OpenAlexW2050433711

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.